Discover investment opportunities in Small Cap Stocks To Buy Now using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Small Cap Stocks To Buy Now using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Small Cap Stocks To Buy Now using our Smart AI Filter.
8 stocks found for "Small Cap Stocks To Buy Now"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.97 | ±38.7% | 24.4 | 0.00% | |||
0.97 | ±100.0% | -55.4 | 0.00% | |||
0.95 | ±100.0% | 102.3 | 0.00% | |||
0.91 | ±55.2% | 48.9 | 1.20% | |||
0.93 | ±47.7% | 21.3 | 0.00% | |||
1.10 | ±53.0% | 17.2 | 4.05% | |||
0.99 | ±46.2% | 34.7 | 0.25% | |||
0.47 | ±28.9% | 17.1 | 0.98% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
The consensus price target hints at a 39.9% upside potential for The Pennant Group (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read moreInnodata Inc. INOD, one of the fastest-growing names in AI data engineering, has seen its shares tumble 18.5% over the past month. The stock has sharply underperformed its peer set, with the Zacks Computer - Services industry down just 0.2% and the broader Zacks Computer and Technology sector up 1.8% over the same period.
Read moreFrom a humble start at $2 in early 2024, SoundHound AI (NASDAQ: SOUN), a voice AI platform enabling businesses to deliver conversational AI experiences, has seen its stock skyrocket by an astonishing 500% to its current price of around $13. This explosive ascent isn't just luck; it's a direct result of the company's compelling AI growth story, which has seen its technology become a staple in the automotive industry and expand into new frontiers.
Read moreDuring times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Read moreDXP Enterprises (DXPE) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Read moreQ: What factors make PLUG a potential buy for growth-focused investors?
A: PLUG Power, specializing in hydrogen fuel cell technology, appeals to investors due to its efforts in renewable energy, aligning with the green energy movement. Growth prospects may hinge on broader adoption of hydrogen solutions and supportive governmental policies. Historically, its stock can be volatile, reflecting sector sentiments.
Q: How does CROX perform as a potential income stock?
A: CROX, known for its iconic footwear, primarily attracts growth investors. It doesn’t typically prioritize dividends, instead reinvesting earnings into expansion efforts. Investors may focus on its brand strength and market penetration for potential appreciation, despite lower income yield.
Q: What industry-specific risks does SCHR face in drug development?
A: SCHR, a drug discovery company, inherently faces regulatory hurdles and high R&D costs. Success is often dependent on clinical trial results and eventual drug approval. Investors must consider the timeline and potential for FDA approval when evaluating risk.
Q: Why might DBI appeal to value investors?
A: Designer Brands Inc. (DBI), a retail footwear company, may appeal to value investors due to its competitive pricing in the retail space and established market presence. Economic cycles can impact its performance, necessitating analysis of consumer spending patterns.
Q: What growth opportunities exist for VRCA in the dermatology market?
A: VRCA, focusing on dermatology treatments, may find growth in expanding its product pipeline and gaining market approval for its therapies. Demand in the skincare sector aligns with broader health trends, offering upside if new treatments are well-received.
Q: Does TUP's historical performance suggest stability for investors?
A: TUP, or Tupperware Brands Corporation, possesses a recognized brand name but may not provide stable returns due to past financial challenges. Economic downturns and competitive pressures can impact performance. Historical volatility requires cautious analysis.